{"entity":{"type":"insider","cik":"0001496687","url":"/insider/0001496687","json_url":"/insider/0001496687.json","name":"Machiels Alec","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":43,"first":"2020-01-17","last":"2023-11-20","span_basis":"filed_date"},"name_variants":[{"name":"Machiels Alec","source":"filing","n_filings":43,"first_seen":"2020-01-17","last_seen":"2023-11-20"}],"transactions":[{"id":8102569,"accession":"0001127602-23-027990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-027990","line_url":"/filing/0001127602-23-027990#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":47.74,"price_display":"47.74","price_state":"stated","total_value":59675.0,"total_display":"59,675.00","total_whole":"59,675","shares_owned_after":367420.0,"shares_owned_after_display":"367,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-17","filed_date":"2023-11-20","scope":"insider"},{"id":8675674,"accession":"0001127602-23-026081","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-026081","line_url":"/filing/0001127602-23-026081#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":48.5,"price_display":"48.50","price_state":"stated","total_value":60625.0,"total_display":"60,625.00","total_whole":"60,625","shares_owned_after":367420.0,"shares_owned_after_display":"367,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-18","scope":"insider"},{"id":7846109,"accession":"0001127602-23-024448","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-024448","line_url":"/filing/0001127602-23-024448#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":56250.0,"total_display":"56,250.00","total_whole":"56,250","shares_owned_after":367420.0,"shares_owned_after_display":"367,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-18","filed_date":"2023-09-19","scope":"insider"},{"id":8003333,"accession":"0001127602-23-024309","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-024309","line_url":"/filing/0001127602-23-024309#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":45.34,"price_display":"45.34","price_state":"stated","total_value":56675.0,"total_display":"56,675.00","total_whole":"56,675","shares_owned_after":367420.0,"shares_owned_after_display":"367,420","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-15","filed_date":"2023-09-18","scope":"insider"},{"id":8055266,"accession":"0001127602-23-020951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-020951","line_url":"/filing/0001127602-23-020951#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":64.79,"price_display":"64.79","price_state":"stated","total_value":80987.5,"total_display":"80,987.50","total_whole":"80,988","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-18","scope":"insider"},{"id":8075589,"accession":"0001127602-23-019158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-019158","line_url":"/filing/0001127602-23-019158#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":88.41,"price_display":"88.41","price_state":"stated","total_value":110512.5,"total_display":"110,512.50","total_whole":"110,513","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-21","scope":"insider"},{"id":8524212,"accession":"0001127602-23-016195","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-016195","line_url":"/filing/0001127602-23-016195#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":88.66,"price_display":"88.66","price_state":"stated","total_value":110825.0,"total_display":"110,825.00","total_whole":"110,825","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":7926556,"accession":"0001127602-23-013129","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-013129","line_url":"/filing/0001127602-23-013129#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":81.05,"price_display":"81.05","price_state":"stated","total_value":101312.5,"total_display":"101,312.50","total_whole":"101,313","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-17","filed_date":"2023-04-18","scope":"insider"},{"id":8292157,"accession":"0001127602-23-010957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-010957","line_url":"/filing/0001127602-23-010957#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":64.03,"price_display":"64.03","price_state":"stated","total_value":80037.5,"total_display":"80,037.50","total_whole":"80,038","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":8474372,"accession":"0001127602-23-006189","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-006189","line_url":"/filing/0001127602-23-006189#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":52.38,"price_display":"52.38","price_state":"stated","total_value":65475.0,"total_display":"65,475.00","total_whole":"65,475","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-17","filed_date":"2023-02-21","scope":"insider"},{"id":7844739,"accession":"0001127602-23-001805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-23-001805","line_url":"/filing/0001127602-23-001805#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":52.42,"price_display":"52.42","price_state":"stated","total_value":65525.0,"total_display":"65,525.00","total_whole":"65,525","shares_owned_after":267641.0,"shares_owned_after_display":"267,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6270825,"accession":"0001127602-22-027856","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-027856","line_url":"/filing/0001127602-22-027856#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":52.35,"price_display":"52.35","price_state":"stated","total_value":65437.5,"total_display":"65,437.50","total_whole":"65,438","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6742056,"accession":"0000899243-22-036194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-036194","line_url":"/filing/0000899243-22-036194#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":48.01,"price_display":"48.01","price_state":"stated","total_value":60012.5,"total_display":"60,012.50","total_whole":"60,013","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-15","filed_date":"2022-11-17","scope":"insider"},{"id":6324398,"accession":"0001127602-22-023984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-023984","line_url":"/filing/0001127602-22-023984#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":59.31,"price_display":"59.31","price_state":"stated","total_value":74137.5,"total_display":"74,137.50","total_whole":"74,138","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-14","filed_date":"2022-10-17","scope":"insider"},{"id":6638636,"accession":"0001127602-22-022540","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-022540","line_url":"/filing/0001127602-22-022540#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":66.0,"price_display":"66.00","price_state":"stated","total_value":82500.0,"total_display":"82,500.00","total_whole":"82,500","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-16","scope":"insider"},{"id":6250058,"accession":"0001127602-22-021109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-021109","line_url":"/filing/0001127602-22-021109#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":67.21,"price_display":"67.21","price_state":"stated","total_value":84012.5,"total_display":"84,012.50","total_whole":"84,013","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-16","scope":"insider"},{"id":6992861,"accession":"0001127602-22-019423","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-019423","line_url":"/filing/0001127602-22-019423#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":46.33,"price_display":"46.33","price_state":"stated","total_value":57912.5,"total_display":"57,912.50","total_whole":"57,913","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-15","filed_date":"2022-07-18","scope":"insider"},{"id":6638341,"accession":"0001127602-22-017795","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-017795","line_url":"/filing/0001127602-22-017795#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":39.29,"price_display":"39.29","price_state":"stated","total_value":49112.5,"total_display":"49,112.50","total_whole":"49,113","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-15","filed_date":"2022-06-17","scope":"insider"},{"id":6360529,"accession":"0001127602-22-014789","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-014789","line_url":"/filing/0001127602-22-014789#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":39.18,"price_display":"39.18","price_state":"stated","total_value":48975.0,"total_display":"48,975.00","total_whole":"48,975","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-17","scope":"insider"},{"id":6816230,"accession":"0001127602-22-012095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-012095","line_url":"/filing/0001127602-22-012095#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":50.9,"price_display":"50.90","price_state":"stated","total_value":63625.0,"total_display":"63,625.00","total_whole":"63,625","shares_owned_after":263774.0,"shares_owned_after_display":"263,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-14","filed_date":"2022-04-18","scope":"insider"},{"id":6740832,"accession":"0000899243-22-011518","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-011518","line_url":"/filing/0000899243-22-011518#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":39.57,"price_display":"39.57","price_state":"stated","total_value":49462.5,"total_display":"49,462.50","total_whole":"49,463","shares_owned_after":259544.0,"shares_owned_after_display":"259,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":6323389,"accession":"0001127602-22-005298","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005298","line_url":"/filing/0001127602-22-005298#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":45.43,"price_display":"45.43","price_state":"stated","total_value":56787.5,"total_display":"56,787.50","total_whole":"56,788","shares_owned_after":673774.0,"shares_owned_after_display":"673,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":6290326,"accession":"0000899243-22-002522","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-002522","line_url":"/filing/0000899243-22-002522#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":40.56,"price_display":"40.56","price_state":"stated","total_value":50700.0,"total_display":"50,700.00","total_whole":"50,700","shares_owned_after":673774.0,"shares_owned_after_display":"673,774","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-19","scope":"insider"},{"id":5450931,"accession":"0001127602-21-031427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-031427","line_url":"/filing/0001127602-21-031427#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":42.88,"price_display":"42.88","price_state":"stated","total_value":128640.0,"total_display":"128,640.00","total_whole":"128,640","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":5409633,"accession":"0001127602-21-029466","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-21-029466","line_url":"/filing/0001127602-21-029466#line-4","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":43.5,"price_display":"43.50","price_state":"stated","total_value":130500.0,"total_display":"130,500.00","total_whole":"130,500","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-15","filed_date":"2021-11-17","scope":"insider"},{"id":5409629,"accession":"0001127602-21-029466","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-029466","line_url":"/filing/0001127602-21-029466#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":105000.0,"total_display":"105,000.00","total_whole":"105,000","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-17","scope":"insider"},{"id":5109684,"accession":"0001127602-21-023884","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-023884","line_url":"/filing/0001127602-21-023884#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":56.95,"price_display":"56.95","price_state":"stated","total_value":142375.0,"total_display":"142,375.00","total_whole":"142,375","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":5468758,"accession":"0001127602-21-022139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-022139","line_url":"/filing/0001127602-21-022139#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":62.3,"price_display":"62.30","price_state":"stated","total_value":155750.0,"total_display":"155,750.00","total_whole":"155,750","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":5288464,"accession":"0001127602-21-020054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-020054","line_url":"/filing/0001127602-21-020054#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":64.83,"price_display":"64.83","price_state":"stated","total_value":162075.0,"total_display":"162,075.00","total_whole":"162,075","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"},{"id":5108765,"accession":"0001127602-21-017172","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-017172","line_url":"/filing/0001127602-21-017172#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.39,"price_display":"45.39","price_state":"stated","total_value":113475.0,"total_display":"113,475.00","total_whole":"113,475","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-14","filed_date":"2021-05-18","scope":"insider"},{"id":5060037,"accession":"0001127602-21-014320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-014320","line_url":"/filing/0001127602-21-014320#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":45.76,"price_display":"45.76","price_state":"stated","total_value":114400.0,"total_display":"114,400.00","total_whole":"114,400","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-21","filed_date":"2021-04-22","scope":"insider"},{"id":4315021,"accession":"0001127602-21-011030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-011030","line_url":"/filing/0001127602-21-011030#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":46.77,"price_display":"46.77","price_state":"stated","total_value":116925.0,"total_display":"116,925.00","total_whole":"116,925","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4951092,"accession":"0001127602-21-006148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-006148","line_url":"/filing/0001127602-21-006148#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":46.0,"price_display":"46.00","price_state":"stated","total_value":115000.0,"total_display":"115,000.00","total_whole":"115,000","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider"},{"id":5460625,"accession":"0001127602-21-001948","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-21-001948","line_url":"/filing/0001127602-21-001948#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":53.15,"price_display":"53.15","price_state":"stated","total_value":132875.0,"total_display":"132,875.00","total_whole":"132,875","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":2754342,"accession":"0001127602-20-031563","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-031563","line_url":"/filing/0001127602-20-031563#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":52.16,"price_display":"52.16","price_state":"stated","total_value":130400.0,"total_display":"130,400.00","total_whole":"130,400","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider"},{"id":2429414,"accession":"0001127602-20-029368","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-029368","line_url":"/filing/0001127602-20-029368#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":39.38,"price_display":"39.38","price_state":"stated","total_value":98450.0,"total_display":"98,450.00","total_whole":"98,450","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2810679,"accession":"0001127602-20-027101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-027101","line_url":"/filing/0001127602-20-027101#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":87500.0,"total_display":"87,500.00","total_whole":"87,500","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-15","filed_date":"2020-10-16","scope":"insider"},{"id":2181503,"accession":"0001127602-20-026750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-026750","line_url":"/filing/0001127602-20-026750#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":262500.0,"total_display":"262,500.00","total_whole":"262,500","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-09","scope":"insider"},{"id":2301351,"accession":"0001127602-20-019733","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-019733","line_url":"/filing/0001127602-20-019733#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.21,"price_display":"30.21","price_state":"stated","total_value":75525.0,"total_display":"75,525.00","total_whole":"75,525","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-16","scope":"insider"},{"id":2257790,"accession":"0001127602-20-017178","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-017178","line_url":"/filing/0001127602-20-017178#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider"},{"id":2746167,"accession":"0001127602-20-014098","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-014098","line_url":"/filing/0001127602-20-014098#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-04-17","scope":"insider"},{"id":2215132,"accession":"0001127602-20-011988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-011988","line_url":"/filing/0001127602-20-011988#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-26","scope":"insider"},{"id":2475005,"accession":"0001127602-20-006429","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-006429","line_url":"/filing/0001127602-20-006429#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":42.35,"price_display":"42.35","price_state":"stated","total_value":105875.0,"total_display":"105,875.00","total_whole":"105,875","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-19","scope":"insider"},{"id":3003781,"accession":"0001127602-20-001921","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-20-001921","line_url":"/filing/0001127602-20-001921#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001496687","owner_name":"Machiels Alec","owner_display_name":"Machiels Alec","owner_url":"/insider/0001496687","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":41.47,"price_display":"41.47","price_state":"stated","total_value":103675.0,"total_display":"103,675.00","total_whole":"103,675","shares_owned_after":669544.0,"shares_owned_after_display":"669,544","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-15","filed_date":"2020-01-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":44,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":44,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":44},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Director","n_filings":43,"first_seen":"2020-01-17","last_seen":"2023-11-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001496687","retrieved_at":"2026-08-25T04:59:39+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}